Voyager Therapeutics, Inc.
Closed-ended linear duplex DNA for non-viral gene transfer

Last updated:

Abstract:

Aspects of the disclosure relate to a nucleic acid comprising a heterologous nucleic acid insert flanked by interrupted self-complementary sequences, wherein one self-complementary sequence is interrupted by a cross-arm sequence forming two opposing, lengthwise-symmetric stem-loops, and wherein the other of the self-complementary sequences is interrupted by a truncated cross-arm sequence. Methods of delivering the nucleic acid to a cell are also provided.

Status:
Grant
Type:

Utility

Filling date:

3 Mar 2017

Issue date:

20 Jul 2021